China Shenghuo Pharmaceutical Holdings, Inc., a China-based pharmaceutical company primarily engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine (TCM), nutritional supplement and cosmetic products, has announced that Raymond Wang has joined the company as part-time Chief Financial Officer, effective April 20, 2011.
He joins China Shenghuo from China Biwin Consulting Co., Ltd. and Guangzhou Biwin Financial Consulting Co., Ltd. where he was responsible for financial consulting, internal controls, tax and Sarbanes-Oxley Section 404 compliance.
Wang began his career at one of Big Four accounting firms where he managed audit engagements, reviewed the working papers, communicated with top management and liaised with internal tax professionals. He later worked at another US accounting firm, where his responsibilities included US GAAP audits, advisory service on the compliance with SOX 404 and pre-audit advisory service, such as enhancing the internal control, preparing financial reports and U.S. GAAP conversion. He holds a Bachelor of Business degree from Guangdong University of Foreign Studies and is a member of the Chinese Institute of Certified Public Accountants (CICPA). He is fluent in English, Mandarin and Cantonese.
The former CFO, Chuanxiang Huang, resigned from his position as CFO of the company, effective April 18, 2011.